---
layout: post
title: About me
author: Ke Yi
tags: [resume]
date: 2023-10-12 11:19 +0800
toc: true
---

# Ke Yi
- Email: kddr_0981@outlook.com

## 1. Field of Specialization
- Biomaterials
- Genome Editing

## 2. Education
<dl>
  <dt>Sichuan University</dt>
  <dd>2015.09 ~ 2019.06</dd>
  <dd>B.S in Biological Science</dd>

  <dt>Sun Yat-sen University</dt>
  <dd>2019.06 ~ 2024.06</dd>
  <dd>Ph.D in Basic Medicine (Molecular Medicine)</dd>
</dl>

## 3. Skills
<dl>
  <dt>Experimental skills</dt>
  <dd> Liposome design and synthesis</dd>
  <dd> Plasmid construction</dd>
  <dd> RT-qPCR, Western blot</dd>
  <dd> Cell culture, Flow cytometry, CLSM microscopy</dd>
  <dd> Construction of orthotopic HCC mouse Model</dd>

  <dt>Software</dt>
  <dd> ImageJ, FlowJo, GraphPad Prism, SnapGene, MestReNova</dd>
  <dd> Word, EndNote, Zotero</dd>
  <dd> Adobe Photoshop, Adobe Illustrator, Blender</dd>

  <dt>General</dt>
  <dd>Language: Chinese as mother tongue, English</dd>
</dl>

## 4. Honor
Ministry of Education of the PRC, National Scholarship 2023

## 5. Publication
1. <mark>Yi, K.</mark>, Kong, H., Lao, Y.-H., Li, D., Mintz, R.L., Fang, T., Chen, G., Tao, Y., Li, M., Ding, J., 2023. Engineered Nanomaterials to Potentiate CRISPR/Cas9 Gene Editing for Cancer Therapy. Adv. Mater. e2300665. [https://doi.org/10.1002/adma.202300665](https://doi.org/10.1002/adma.202300665)
2. <mark>Yi, K.</mark>, Kong, H., Zheng, C., Zhuo, C., Jin, Y., Zhong, Q., Mintz, R.L., Ju, E., Wang, H., Lv, S., Lao, Y.-H., Tao, Y., Li, M., 2023. A LIGHTFUL nanomedicine overcomes EGFR-mediated drug resistance for enhanced tyrosine-kinase-inhibitor-based hepatocellular carcinoma therapy. Biomaterials 122349. [https://doi.org/10.1016/j.biomaterials.2023.122349](https://doi.org/10.1016/j.biomaterials.2023.122349)
3. Tao, Y., <mark>Yi, K.</mark>, Wang, H., Kim, H.-W., Li, K., Zhu, X., Li, M., 2022. CRISPR-Cas12a-regulated DNA adsorption and metallization on MXenes as enhanced enzyme mimics for sensitive colorimetric detection of hepatitis B virus DNA. J Colloid Interface Sci 613, 406–414. [https://doi.org/10.1016/j.jcis.2022.01.038](https://doi.org/10.1016/j.jcis.2022.01.038)
4. Tao, Y., <mark>Yi, K.</mark>, Hu, H., Shao, D., Li, M., 2021. Coassembly of nucleus-targeting gold nanoclusters with CRISPR/Cas9 for simultaneous bioimaging and therapeutic genome editing. Journal of Materials Chemistry. B Online ahead of print. [https://doi.org/10.1039/d0tb01925a](https://doi.org/10.1039/d0tb01925a)
5. Dang, W., <mark>Yi, K.</mark>, Ju, E., Jin, Y., Xu, Y., Wang, H., Chen, W.-C., Wang, K., Wang, Y., Tao, Y., Li, M., 2021b. 3D Printed Bioceramic Scaffolds as a Universal Therapeutic Platform for Synergistic Therapy of Osteosarcoma. Acs Applied Materials & Interfaces 13, 18488–18499. [https://doi.org/10.1021/acsami.1c00553](https://doi.org/10.1021/acsami.1c00553)
6. Tao, Y., <mark>Yi, K.</mark>, Wang, H., Li, K., Li, M., 2022b. Metal nanoclusters combined with CRISPR-Cas12a for hepatitis B virus DNA detection. Sensors and Actuators B-Chemical 361, 131711. [https://doi.org/10.1016/j.snb.2022.131711](https://doi.org/10.1016/j.snb.2022.131711)
7. Kong, H., <mark>Yi, K.</mark>, Zheng, C., Lao, Y.-H., Zhou, H., Chan, H.F., Wang, H., Tao, Y., Li, M., 2022. Membrane-fusogenic biomimetic particles: a new bioengineering tool learned from nature. J. Mater. Chem. B 10, 6841–6858. [https://doi.org/10.1039/D2TB00632D](https://doi.org/10.1039/D2TB00632D)
8. Guan, Y., Yao, W., <mark>Yi, K.</mark>, Zheng, C., Lv, S., Tao, Y., Hei, Z., Li, M., 2021. Nanotheranostics for the Management of Hepatic Ischemia-Reperfusion Injury. Small 17, 2007727. [https://doi.org/10.1002/smll.202007727](https://doi.org/10.1002/smll.202007727)
9. Dang, W., Jin, Y., <mark>Yi, K.</mark>, Ju, E., Zhuo, C., Wei, H., Wen, X., Wang, Y., Li, M., Tao, Y., 2021a. Hemin particles-functionalized 3D printed scaffolds for combined photothermal and chemotherapy of osteosarcoma. Chem. Eng. J. 422, 129919. [https://doi.org/10.1016/j.cej.2021.129919](https://doi.org/10.1016/j.cej.2021.129919)
10. Jin, Y., Wang, H., <mark>Yi, K.</mark>, Lv, S., Hu, H., Li, M., Tao, Y., 2021. Applications of Nanobiomaterials in the Therapy and Imaging of Acute Liver Failure. Nano-micro Lett. 13, 25. [https://doi.org/10.1007/s40820-020-00550-x](https://doi.org/10.1007/s40820-020-00550-x)
11. Jin, Y., Zhang, J., Xu, Y., <mark>Yi, K.</mark>, Li, F., Zhou, H., Wang, H., Chan, H.F., Lao, Y.-H., Lv, S., Tao, Y., Li, M., 2023. Stem cell-derived hepatocyte therapy using versatile biomimetic nanozyme incorporated nanofiber-reinforced decellularized extracellular matrix hydrogels for the treatment of acute liver failure. Bioactive Materials 28, 112–131. [https://doi.org/10.1016/j.bioactmat.2023.05.001](https://doi.org/10.1016/j.bioactmat.2023.05.001)
12. Kong, H., Ju, E., <mark>Yi, K.</mark>, Xu, W., Lao, Y.-H.</mark>, Cheng, D., Zhang, Q., Tao, Y., Li, M., Ding, J., 2021. Advanced Nanotheranostics of CRISPR/Cas for Viral Hepatitis and Hepatocellular Carcinoma. Adv. Sci. 8, 2102051. [https://doi.org/10.1002/advs.202102051](https://doi.org/10.1002/advs.202102051)
13. Li, F., Zhang, J., <mark>Yi, K.</mark>, Wang, H., Wei, H., Chan, H.F., Tao, Y., Li, M., 2022. Delivery of Stem Cell Secretome for Therapeutic Applications. ACS applied bio materials 5, 2009–2030. [https://doi.org/10.1021/acsabm.1c01312](https://doi.org/10.1021/acsabm.1c01312)
14. Tao, Y., Lao, Y.-H., <mark>Yi, K.</mark>, Xu, Y., Wang, H., Shao, D., Wang, J., Li, M., 2021a. Noble metal-molybdenum disulfide nanohybrids as dual fluorometric and colorimetric sensor for hepatitis B virus DNA detection. Talanta 234, 122675. [https://doi.org/10.1016/j.talanta.2021.122675](https://doi.org/10.1016/j.talanta.2021.122675)
15. Zheng, C., Zhong, Q., <mark>Yi, K.</mark>, Kong, H., Cao, F., Zhuo, C., Xu, Y., Shi, R., Ju, E., Song, W., Tao, Y., Chen, X., Li, M., 2023b. Anti-phagocytosis-blocking repolarization-resistant membrane-fusogenic liposome (ARMFUL) for adoptive cell immunotherapy. Sci. Adv. 9, eadh2413. [https://doi.org/10.1126/sciadv.adh2413](https://doi.org/10.1126/sciadv.adh2413)
16. Zhong, Q., Zheng, C., <mark>Yi, K.</mark>, Mintz, R.L., Lv, S., Tao, Y., Li, M., 2023. Structural and componential design: new strategies regulating the behavior of lipid-based nanoparticles in vivo. Biomater. Sci. 11, 4774–4788. [https://doi.org/10.1039/d3bm00387f](https://doi.org/10.1039/d3bm00387f)
17. Zhuo, C., Kong, H., <mark>Yi, K.</mark>, Chi, C.-W., Zhang, J., Chen, R., Wang, H., Wu, C., Lao, Y.-H., Tao, Y., Li, M., 2023. Magnetic-Activated Nanosystem with Liver-Specific CRISPR Nonviral Vector to Achieve Spatiotemporal Liver Genome Editing as Hepatitis B Therapeutics. Adv. Funct. Mater. 33, 2210860. [https://doi.org/10.1002/adfm.202210860](https://doi.org/10.1002/adfm.202210860)
18. Zheng, C., Zhong, Q., Song, W., <mark>Yi, K.</mark>, Kong, H., Wang, H., Tao, Y., Li, M., Chen, X., 2023a. Membrane-Fusion-Mediated Multiplex Engineering of Tumor Cell Surface Glycans for Enhanced NK Cell Therapy. Adv. Mater. n/a, 2206989. [https://doi.org/10.1002/adma.202206989](https://doi.org/10.1002/adma.202206989)
19. Qin, Y., Lao, Y.-H., Wang, H., Zhang, J., <mark>Yi, K.</mark>, Chen, Z., Han, J., Song, W., Tao, Y., Li, M., 2021. Combatting Helicobacter pylori with oral nanomedicines. J. Mater. Chem. B 9, 9826–9838. [https://doi.org/10.1039/d1tb02038b](https://doi.org/10.1039/d1tb02038b)
